| 000 | 01721 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513164207.0 | ||
| 264 | 0 | _c19990301 | |
| 008 | 199903s 0 0 eng d | ||
| 022 | _a0006-3002 | ||
| 024 | 7 |
_a10.1016/s0167-4889(98)00156-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGiardina, C | |
| 245 | 0 | 0 |
_aNSAIDs and butyrate sensitize a human colorectal cancer cell line to TNF-alpha and Fas ligation: the role of reactive oxygen species. _h[electronic resource] |
| 260 |
_bBiochimica et biophysica acta _cJan 1999 |
||
| 300 |
_a425-38 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylcysteine _xpharmacology |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
| 650 | 0 | 4 |
_aAntibodies _xpharmacology |
| 650 | 0 | 4 |
_aAntioxidants _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aButyrates _xpharmacology |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFas Ligand Protein |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrogen Peroxide _xpharmacology |
| 650 | 0 | 4 |
_aIndomethacin _xpharmacology |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 |
_aSalicylic Acid _xpharmacology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
| 700 | 1 | _aBoulares, H | |
| 700 | 1 | _aInan, M S | |
| 773 | 0 |
_tBiochimica et biophysica acta _gvol. 1448 _gno. 3 _gp. 425-38 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0167-4889(98)00156-6 _zAvailable from publisher's website |
| 999 |
_c9951692 _d9951692 |
||